Repligen Corp. (RGEN)
181.70
+4.47
(+2.52%)
USD |
NASDAQ |
Oct 02, 16:00
181.62
-0.08
(-0.04%)
After-Hours: 20:00
Repligen Market Cap : 10.25B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 10.25B |
| October 01, 2026 | 10.00B |
| September 30, 2026 | 10.85B |
| September 29, 2026 | 10.98B |
| September 28, 2026 | 10.95B |
| September 25, 2026 | 10.70B |
| September 24, 2026 | 10.76B |
| September 23, 2026 | 10.41B |
| September 22, 2026 | 10.54B |
| September 21, 2026 | 10.20B |
| September 18, 2026 | 9.981B |
| September 17, 2026 | 10.05B |
| September 16, 2026 | 9.757B |
| September 15, 2026 | 9.860B |
| September 14, 2026 | 9.480B |
| September 11, 2026 | 9.321B |
| September 10, 2026 | 9.292B |
| September 09, 2026 | 9.313B |
| September 08, 2026 | 9.510B |
| September 04, 2026 | 9.457B |
| September 03, 2026 | 9.571B |
| September 02, 2026 | 9.759B |
| September 01, 2026 | 9.594B |
| August 31, 2026 | 10.21B |
| August 28, 2026 | 9.946B |
| Date | Value |
|---|---|
| August 27, 2026 | 10.27B |
| August 26, 2026 | 10.17B |
| August 25, 2026 | 10.25B |
| August 24, 2026 | 10.25B |
| August 21, 2026 | 10.22B |
| August 20, 2026 | 10.17B |
| August 19, 2026 | 9.951B |
| August 18, 2026 | 9.375B |
| August 17, 2026 | 9.538B |
| August 14, 2026 | 9.414B |
| August 13, 2026 | 9.451B |
| August 12, 2026 | 9.350B |
| August 11, 2026 | 9.297B |
| August 10, 2026 | 9.207B |
| August 07, 2026 | 9.248B |
| August 06, 2026 | 8.997B |
| August 05, 2026 | 8.949B |
| August 04, 2026 | 8.452B |
| August 03, 2026 | 8.298B |
| July 31, 2026 | 7.957B |
| July 30, 2026 | 8.103B |
| July 29, 2026 | 7.969B |
| July 28, 2026 | 8.201B |
| July 27, 2026 | 7.395B |
| July 24, 2026 | 7.446B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLife Solutions, Inc. | 1.824B |
| Precigen, Inc. | 3.057B |
| Liquidia Corp. | 2.552B |
| Harmony Biosciences Holdings, Inc. | 2.304B |
| Bio-Techne Corp. | 11.30B |
Market Cap Related Metrics
| PE Ratio | 247.65 |
| PS Ratio | 13.10 |
| Price to Book Value | 4.854 |
| Price to Free Cash Flow | 93.40 |
| Price | 181.70 |
| Earnings Yield | 0.40% |
| Operating PE Ratio | 145.06 |
| Normalized PE Ratio | 222.62 |